Ignite Creation Date:
2024-05-06 @ 7:18 PM
Last Modification Date:
2024-10-26 @ 3:04 PM
Study NCT ID:
NCT05965375
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-04
First Post:
2023-07-06
Brief Title:
Risk Stratification Value of Biomarkers in Patients With Ventricular Arrhythmias
Sponsor:
First Affiliated Hospital Xian Jiaotong University
Organization:
First Affiliated Hospital Xian Jiaotong University
Study Overview
Official Title:
Risk Stratification Value of Biomarkers in Patients With Ventricular Arrhythmias FUTURE an Investigator-initiated National Multicenter Retrospective-prospective Cohort Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
FUTURE
Brief Summary:
The investigation of biomarkers for immune status and metabolic state as well as host microbiota composition in patients with ventricular arrhythmias before and after radiofrequency ablation can provide new insights for specific and personalized treatment This can help establish early prediction and prognosis models and provide a basis for clinically effective diagnosis and treatment
Detailed Description:
Abnormal immune and metabolic states can lead to the occurrence of various systemic diseases including the development of cardiovascular diseases through multiple mechanisms On the other hand various diseases can also feedback and regulate the immune and metabolic systems However currently there is no research on the impact of immune and metabolic states on ventricular arrhythmia Exploring the biomarker characteristics and risk stratification of patients with ventricular arrhythmias undergoing radiofrequency ablation before and after the procedure can provide new insights for specific and personalized treatment It can establish early prediction and prognostic models providing evidence for clinically effective diagnosis and treatment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None